» Articles » PMID: 8756808

Ultrasonic Nebulized in Comparison with Instilled Surfactant Treatment of Preterm Lambs

Overview
Specialty Critical Care
Date 1996 Aug 1
PMID 8756808
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

To evaluate the efficiency and distribution of ultrasonic nebulized versus instilled surfactant in the treatment of surfactant deficiency at varying degrees of maturation, twin or triplet lamb fetuses were delivered at 125 to 137 d gestational age and received nebulized natural surfactant (Neb Only), instilled surfactant followed by a second instilled dose (Inst/Inst), instilled surfactant followed by nebulized surfactant (Inst/Neb), or no surfactant (Control). The lambs were ventilated for 6 h. Twenty-eight lambs were categorized into two groups (low compliance versus moderate compliance) based on initial physiologic lung characteristics. Efficiency of deposition of nebulized surfactant directly correlated with the compliances and ventilatory efficiency indices measured at 15 min of age. The low-compliance group (Low Comp) had significantly lower efficiency of surfactant deposition (7.6 +/- 1.6%) than did the moderate-compliance group (Mod Comp) (23.4 +/- 2.5%) (p < 0.01). Overall, instilled surfactant had a reasonably homogeneous distribution, whereas nebulized surfactant had a less homogeneous distribution, except for the Low Comp, Inst/Neb group, which had a distribution pattern similar to that for instilled surfactant. The potential for nebulized surfactant therapy for respiratory distress syndrome (RDS) may be limited by the nonhomogeneous nature of ventilation in the preterm lung.

Citing Articles

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome.

Brasher M, Raffay T, Cunningham M, Abu Jawdeh E Children (Basel). 2021; 8(6).

PMID: 34200535 PMC: 8228799. DOI: 10.3390/children8060493.


Nebulized Poractant Alfa Reduces the Risk of Respiratory Failure at 72 Hours in Spontaneously Breathing Surfactant-Deficient Newborn Piglets.

Rey-Santano C, Mielgo V, Gomez-Solaetxe M, Bianco F, Salomone F, Loureiro B Crit Care Med. 2020; 48(6):e523-e531.

PMID: 32301841 PMC: 7237025. DOI: 10.1097/CCM.0000000000004318.


Dose-Response Study on Surfactant Nebulization Therapy During Nasal Continuous Positive Airway Pressure Ventilation in Spontaneously Breathing Surfactant-Deficient Newborn Piglets.

Rey-Santano C, Mielgo V, Gomez-Solaetxe M, Ricci F, Bianco F, Salomone F Pediatr Crit Care Med. 2020; 21(7):e456-e466.

PMID: 32195907 PMC: 7326365. DOI: 10.1097/PCC.0000000000002313.


Mass spectrometry imaging as a tool for evaluating the pulmonary distribution of exogenous surfactant in premature lambs.

Zecchi R, Franceschi P, Tigli L, Ricci F, Boscaro F, Pioselli B Respir Res. 2019; 20(1):175.

PMID: 31382955 PMC: 6683365. DOI: 10.1186/s12931-019-1144-5.


From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy.

Bianco F, Ricci F, Catozzi C, Murgia X, Schlun M, Bucholski A Respir Res. 2019; 20(1):134.

PMID: 31266508 PMC: 6604359. DOI: 10.1186/s12931-019-1096-9.